Park West Asset Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Park West Asset Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-62,200	Closed	-$43K	–	108
2021 Q4	$43K	Hold	62,200	–	–	﹤0.01%	147
2021 Q3	$87K	Hold	62,200	–	–	﹤0.01%	158
2021 Q2	$108K	Hold	62,200	–	–	﹤0.01%	171
2021 Q1	$84K	Buy	+62,200	New	+$115K	﹤0.01%	171

Other funds holding STLNW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

USPCM

Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Park West Asset Management's STLNW Position: Q1 2022 in Review

Park West Asset Management sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2022, closing a stake of 62,200 shares — an estimated $43K sold.

Park West Asset Management first reported a position in STLNW in Q1 2021 and held it in 4 quarters. The position peaked at $108K in Q2 2021. 12 funds tracked by Wall St. Rank hold STLNW as of Q1 2022.

Park West Asset Management reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
Park West Asset Management sold 62,200 Starling Oncology, Inc. Warrant shares in Q1 2022, an estimated $43K.
Park West Asset Management first reported a position in Starling Oncology, Inc. Warrant in Q1 2021 and held it in 4 quarters.
Park West Asset Management's Starling Oncology, Inc. Warrant position peaked at $108K in Q2 2021.
12 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2022.

Based on Park West Asset Management's 13F filing for Q1 2022, filed 16 May 2022.